I asked ChatGPT about Riway International’s Sales Revenue

Determining the exact sales revenue of Riway International’s flagship product, Purtier Placenta, is challenging due to limited publicly available financial data. However, some insights can be gleaned from various sources:

• Revenue Growth: During a presentation at Riway’s office in Ang Mo Kio, a seller claimed that the company’s revenue grew from US$3 million in 2009 to US$4 billion in 2017, attributing this growth to the success of Purtier Placenta.
• Product Sales: As of March 2023, over 10 million bottles of Purtier Placenta had been sold globally.
• Pricing: The price of a single bottle (60 capsules) of Purtier Placenta was set at S$615 (approximately US$450) as of March 2023.

Using these figures, the estimated revenue from Purtier Placenta sales would be approximately US$4.5 billion (10 million bottles x US$450 per bottle). However, it’s important to note that this is a rough estimate, and actual revenue figures may vary.

Additionally, Riway International has faced regulatory scrutiny. In 2019, the Health Sciences Authority (HSA) of Singapore warned the company against making false claims that Purtier Placenta could treat or cure cancer. Subsequently, in July 2021, Riway was fined S$3,000 for these misleading claims.

Given these factors, while Purtier Placenta appears to have contributed significantly to Riway International’s revenue, precise and current sales figures are not publicly disclosed.